About Delphinus Medical Technologies
Delphinus Medical Technologies is a Healthcare company based in Plymouth (United States) founded in 2010 by Neb Duric. Platform for breast ultrasound imaging. Delphinus Medical Technologies has raised $136.54 million across 14 funding rounds from investors including HHS, GE Capital and Trinity Cap. Its chief executive, as recorded, is Scott A White. Delphinus Medical Technologies offers products and services including SoftVue. Its focus areas include Life Sciences, Oncology, Medical Devices and Imaging. Its competitors include CairnSurgical, Oncovision and QT Imaging; 3 of its 3 listed competitors have raised funding.
Company details
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines womens breasts for the presence of benign andor malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
- Headquarters Plymouth, United States
- Founders Neb Duric
- SectorsHealthcare
- Website delphinusmt.com
- Social LinkedIn X YouTube
- Legal Name Delphinus Medical Technologies
- Total Equity Funding$136.54M (USD)
in 14 rounds
- Latest Funding Round$27.6M (USD), Series D
Mar 2024
- InvestorsHHS
& 10 more
Products & Services of Delphinus Medical Technologies
Delphinus Medical Technologies offers a comprehensive portfolio of products and services, including SoftVue.
Offers 3D tomography for detecting breast cancer in dense tissues.
Apps and channels of Delphinus Medical Technologies
its YouTube channel Delphinus Medical Technologies, Inc. has 279 subscribers and 26 videos.
Videos from Delphinus Medical Technologies
The most watched videos on Delphinus Medical Technologies's YouTube channel, Delphinus Medical Technologies, Inc. (279 subscribers). Click a video to play it here.
More on Delphinus Medical Technologies, Inc..
Funding Insights of Delphinus Medical Technologies
Delphinus Medical Technologies has successfully raised a total of $136.54M across 14 strategic funding rounds. The most recent funding activity was a Series D round of $27.6 million completed in March 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $136.54M
- Total Rounds 14
- Last Round Series D — $27.6M
- Investors Count 11
Latest 10 of 14 funding rounds of Delphinus Medical Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2024 | $27.6M | Series D | – | – | – |
| Aug 2023 | $12M | Debt – Venture | – | – | |
| Jun 2023 | $5M | Series D | – | – | – |
| Sep 2022 | $30M | Series D | – | – | |
| Apr 2017 | $8.23M | Series C | – | – | – |
| Sep 2015 | $39.55M | Series C | – | Venture Investors | |
| Jul 2014 | $184,242 | Grant | – | – | |
| Sep 2013 | $6M | Debt – Conventional | – | – | |
| Sep 2013 | $11M | Series B | – | – | |
| Sep 2012 | $3.77M | Grant | – | – |
11 investors in total: 11 institutional.
Investors in Delphinus Medical Technologies
Delphinus Medical Technologies has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, GE Capital and Trinity Cap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt and equipment financing are provided to growth-stage companies. | 2008 | trinitycap.com | Phoenix, United States | |
Healthcare venture capital investments are made by Arboretum Ventures. | arboretumvc.com | Ann Arbor, United States | ||
Investments are made in growth-stage startups by Beringea. | beringea.com | Farmington Hills, United States | ||
Early-stage venture capital is invested in US technology sectors. | northcoastvc.com | Ann Arbor, United States | ||
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia | ventureinvestors.com | Madison, United States | ||
| hopenls.com | ||||
Venture capital firm investing in multiple sectors | Menlo Park, United States | |||
| zli.umich.edu/wolverine-venture-fund | ||||
Private equity investments are directed toward US companies. | investmichiganfund.com | Michigan, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Delphinus Medical Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Delphinus Medical Technologies
15 people are tracked at Delphinus Medical Technologies (11 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Neb Duric | Co-Founder & Chief Technology Officer | Leadership |
Scott A White | CEO & President | Leadership |
Mark J Forchette | President & CEO | Leadership |
Peter Littrup | Chief Medical Officer | Leadership |
Dane Baruzzini | Vice President, Operations | Leadership |
Scott White | Chief Commercial Officer (CCO) | Leadership |
John Leonard | Director Of Strategic Accounts | Leadership |
Christine J. Wright | Director Of Customer Success | Leadership |
Rama Gundlapalli | Vice President Of Engineering | Leadership |
Oliver Haswell | Director Of Strategic Accounts | Leadership |
Jason Volm | Director Of Strategic Accounts | Leadership |
Shelly Brown | Logistics Manager | Team |
Cuiping Li | Principal Clinical Scientist | Team |
Reem Omer | Manufacturing Engineer | Team |
Sean Hatch | Senior Ultrasound Engineer | Team |
Complete people profiles for Delphinus Medical Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Delphinus Medical Technologies
3 dated milestones of Delphinus Medical Technologies across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Delphinus Medical Technologies is founded.
- Funding First funding round.
- Funding Latest funding round, Series D, of $27.6M.
Competitors of Delphinus Medical Technologies
Delphinus Medical Technologies has 3 listed competitors in our database, 3 of them funded. They include CairnSurgical, Oncovision and QT Imaging.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cairnsurgical.com | 2015 | Lebanon, United States | $7.79M | Developer of 3D printed surgical guides for breast cancer treatment | ||
| oncovision.com | 2003 | Boston, United States | $3.84M | Diagnostic imaging devices for oncology are manufactured and provided. | ||
| qtimaging.com | 2012 | Novato, United States | $28.8M | Non-invasive ultrasound device for breast cancer detection is developed. |
Detailed competitors of Delphinus Medical Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Delphinus Medical Technologies
Websites that share an audience with Delphinus Medical Technologies (delphinusmt.com).
Websites whose visitors overlap most with Delphinus Medical Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
weinsteinimaging.com | weinsteinimaging.com | 100% | #3,738,133 | – |
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Delphinus Medical Technologies (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Delphinus Medical Technologies
Complete news archive for Delphinus Medical Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delphinus Medical Technologies
Delphinus Medical Technologies was founded in 2010.
Delphinus Medical Technologies is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
Scott A White is the CEO of Delphinus Medical Technologies, as recorded in our data.
Delphinus Medical Technologies is a funded company, having raised a total of $136.54M across 14 funding rounds to date. The company's 1st funding round was a Grant of $3.77M, raised on May 2010.
Delphinus Medical Technologies has designed and developed SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines womens breasts for the presence of benign andor malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. Sound and water are the basis of its technology, where acoustic signals resonating within breast tissue yield a unique signature that it measures. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography.
Delphinus Medical Technologies's top competitors include QT Imaging, CairnSurgical and Oncovision.
Delphinus Medical Technologies offers SoftVue.
Delphinus Medical Technologies has 11 investors. Key investors include HHS, GE Capital, Trinity Cap, Arboretum Ventures, and Beringea.
Delphinus Medical Technologies operates through Delphinus Medical Technologies.